1–5 of 5 results for type 2 diabetes
The Association of Pars Plana Vitrectomy With the Progression From Nonproliferative to Proliferative Diabetic Retinopathy
Ahmed Sallam, MD PhD FRCOphth
Annual Meeting Talks
2025
Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
2024
Association Between Age-Related Macular Degeneration and Diabetic Retinopathy in Type 2 Diabetes Mellitus: A Retrospective Study Using the Vestrum Health Database
Daniel A. Adelberg, MD, FASRS
Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Updates from the Field
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
2022